Stockscreener 앱 받기
46.23
0.00%
0.00
시간 외 거래:
46.20
-0.03
-0.06%
Springworks Therapeutics Inc 주식(SWTX)의 최신 뉴스
ArrowMark Colorado Holdings LLC Acquires 7,072 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Soros Fund Management LLC Purchases 41,149 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics (NASDAQ:SWTX) Rating Lowered to Hold at Evercore ISI - MarketBeat
Merck KGaA (MKGAF) to Acquire SpringWorks Therapeutics for $3.9 Billion - GuruFocus
(SWTX) Trading Report - news.stocktradersdaily.com
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by Ally Bridge Group NY LLC - MarketBeat
Boxer Capital Management LLC Acquires New Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics' (SWTX) "Hold" Rating Reiterated at TD Cowen - MarketBeat
Merck KGaA’s $3.9 Billion Springworks Deal to Boost US Presence - MSN
SpringWorks Therapeutics (NASDAQ:SWTX) Shares Gap UpHere's Why - MarketBeat
Brokerages Set SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Price Target at $63.17 - MarketBeat
Wedbush Reiterates "Neutral" Rating for SpringWorks Therapeutics (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics (NASDAQ:SWTX) Receives "Equal Weight" Rating from Barclays - MarketBeat
Price T Rowe Associates Inc. MD Sells 241,632 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by Nebula Research & Development LLC - MarketBeat
SpringWorks Therapeutics’ (SWTX) “Neutral” Rating Reiterated at HC Wainwright - Defense World
Top Mid Cap Stocks Worth WatchingApril 28th - MarketBeat
Voya Investment Management LLC Acquires 67,559 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Taxation With Representation: Goodwin, Haynes Boone - Law360
SpringWorks Therapeutics' (SWTX) "Neutral" Rating Reiterated at HC Wainwright - MarketBeat
Lord Abbett & CO. LLC Trims Stock Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RGLS, KRON, SWTX on Behalf of Shareholders - marketscreener.com
Biotech Alert: Searches spiking for these stocks today - Yahoo Finance
TD Cowen Reaffirms Hold Rating for SpringWorks Therapeutics (NASDAQ:SWTX) - Defense World
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Receives $63.17 Consensus Price Target from Brokerages - Defense World
SpringWorks Therapeutics (NASDAQ:SWTX) Cut to “Hold” at Evercore ISI - Defense World
SpringWorks Therapeutics (SWTX) Downgraded Amid Acquisition Deal - GuruFocus
13,556 Shares in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Purchased by Syon Capital LLC - MarketBeat
SPRINGWORKS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of SpringWorks Therapeutics, Inc.SWTX - Business Wire
HC Wainwright Downgrades Springworks Therapeutics to Neutral From Buy, Adjusts Price Target to $47 From $74 - marketscreener.com
SpringWorks Therapeutics (SWTX) Downgraded by H.C. Wainwright Du - GuruFocus
SpringWorks Therapeutics (NASDAQ:SWTX) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
Merck KGaA Nears Deal to Buy SpringWorks Therapeutics - MSN
Merck KGaA to Buy US Biotech Springworks for $3.9 Billion - MSN
Germany's Merck KGaA in $3.9 billion deal to buy US biotech firm SpringWorks - Reuters
Merck’s $3.9 Billion Acquisition of SpringWorks Therapeutics - Global Legal Chronicle
SpringWorks: Acquired By Merck KGaA Based On Rare Tumor Targeting Drugs Like OGSIVEO - Seeking Alpha
Merck KGaA to Acquire SpringWorks for $3.9B, Expanding Rare Cancer Footprint - Genetic Engineering and Biotechnology News
Wall Street Analysts Believe SpringWorks Therapeutics (SWTX) Could Rally 42.29%: Here's is How to Trade - Yahoo Finance
Guggenheim Downgrades Springworks Therapeutics to Neutral From Buy, Adjusts Price Target to $47 From $77 - marketscreener.com
TD Cowen Downgrades Springworks Therapeutics to Hold From Buy, Adjusts Price Target to $47 From $66 - marketscreener.com
Germany’s Merck KGaA in $3.9 billion deal to buy US biotech firm SpringWorks - 1330 & 101.5 WHBL
SpringWorks Therapeutics Retail Chatter Spikes As Germany’s Merck Confirms Late-Stage Talks For $3.5B Buyout - MSN
BofA Keeps Merck at Buy Amid SpringWorks Acquisition - marketscreener.com
SpringWorks Therapeutics (SWTX) to Release Earnings on Thursday - MarketBeat
Merck to acquire US-based biotech firm SpringWorks for $3.9bn - World Pharmaceutical Frontiers
German pharma giant Merck to acquire US biotech firm SpringWorks in $3.9B deal - Türkiye Today
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of SpringWorks Therapeutics, Inc.SWTX - The Malaysian Reserve
Merck KGaA to Acquire SpringWorks Therapeutics (SWTX) for $3.9 B - GuruFocus
SpringWorks Therapeutics (SWTX) Downgraded Amid Acquisition Deal | SWTX Stock News - GuruFocus
Merck To Buy SpringWorks Therapeutics For $3.9 Billion, Marking Major Expansion - MSN
0.39%
3.66%
자본화:
|
볼륨(24시간):